In vivo loss of heterozygosity in T-cells of B6C3F1 Aprt(+/-) mice

Environmental and Molecular Mutagenesis

Volumn 35, Issue 2, 2000, Pages 150-157

  Liang, Li ^a,b   Deng, Li ^b   Shao, Changshun ^b   Stambrook, Peter J ^c   Tischfield, Jay A ^b,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Aprt; In vivo loss of heterozygosity; Mouse T cells

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER; GENE LOCUS; HETEROZYGOSITY LOSS; MOUSE; MUTAGENESIS; NONHUMAN; T LYMPHOCYTE;

ADENINE PHOSPHORIBOSYLTRANSFERASE; ANIMALS; BASE SEQUENCE; DNA PRIMERS; HUMANS; LOSS OF HETEROZYGOSITY; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

ANIMALIA;

EID: 0034023477     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(2000)35:2<150::AID-EM10>3.0.CO;2-0     Document Type: Article

References (35)

1. Albertini RJ, Castle KL, Borcherdine WR. 1982. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci USA 79:6617-6621.
2. Atkins JH, Gartler SM. 1968. Development of a nonselective technique for studying 2,6-diaminopurine resistance on an established murine cell line. Genetics 60:781-792.
3. Barren JC. 1981. Induction of gene mutation in and cell transformation of mammalian cells by modified purines: 2-aminopurine and 6-N-hydroxylaminopurine. Proc Natl Acad Sci USA 78:5685-5689.
4. Bell EB, Sparshott SM. 1997. The peripheral T-cell poll: regulation by non-antigen induced proliferation? Semin Immunol 9:347-353.
5. Boynton RF, Blount PL, Yin J, Brown VL, Huang Y, Tong Y, McDaniel T, Newkirk C, Resau JH, Raskind WH, Haggitt RC, Reid BJ, Meltzer SJ. 1992. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA 89:3385-3388.
6. Cappione AJ, French BL, Skuse GR. 1997. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Am J Hum Genet 60: 305-312.
7. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. 1983. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784.
8. Davis LM, Caspary WJ, Sakallah SA, Maronpot R, Wiseman R, Barrett JC, Elliott R, Hozier JC. 1994. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis 15:1637-1645.
9. de Jong PJ, Grosovsky AJ, Glickman BW. 1988. Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: an analysis at the DNA sequence level. Proc Natl Acad Sci USA 85:3499-3503.
10. Dempsey JL, Morley AA. 1986. Measurement of in vivo mutant frequency in lymphocytes in the mouse. Environ Mol Mutagen 8:385-391.
11. Dickerman LH, Tischfield JA. 1978. Comparative effects of adenine analogs upon metabolic cooperation between Chinese hamster cells with different levels of adenine phosphoribosyltransferase activity. Mutat Res 49:83-94.
12. Dush MK, Sikela JM, Khan SA, Tischfield JA, Stambrook PJ. 1985. Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene: presence of a coding region common to animal and bacterial phosphoribosyltransferases that has a variable intron/exon arrangement. Proc Natl Acad Sci USA 82:2731-2735.
13. Engle SJ, Stockelman MG, Chen J, Boivin G, Yum M-N, Davies PM, Ying MY, Sahota A, Simmonds HA, Stambrook PJ, Tischfield JA. 1996. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc Natl Acad Sci USA 93:5307-5312.
14. Gascoigne NRJ, Chien Y-h, Becker DM, Kavaler J, Davis MM. 1984. Genomic organization and sequence of T-cell receptor β-chain constant-and joining-region genes. Nature 310:387-391.
15. Gocke E, Eckhardt K, King M-T, Wild D. 1983. Autoradiographic detection of 6-thioguanine-resistant lymphocytes of mice. Mutat Res 113:455-465.
16. Gupta PK, Sahota A, Boyadjiev SA, Bye S, Shao C, O'Neill JP, Hunter TC, Albertini RJ, Stambrook PJ, Tischfield JA. 1997. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination. Cancer Res 57:1188-1193.
17. Hakoda M, Nishioka K, Kamatani N. 1990. Homozygous deficiency at autosomal locus aprt in human somatic cells in vivo induced by two different mechanisms. Cancer Res 50:1738-1741.
18. Jone IM, Burkhart-Schultz K, Carrano AV. 1985. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutat Res 147:97-105.
19. Lasko D, Cavenee W, Nordenskjöld M. 1991. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25:281-314.
20. Liggett WH, Sidransky D. 1998. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16:1197-1206.
21. Meng Q, Skopek TR, Walker DM, Hurley-Leslie S, Chen T, Zimmer DM, Walker VE. 1998a. Culture and propagation of Hprt mutant T-lymphocytes isolated from mouse spleen. Environ Mol Mutagen 32:236-243.
22. Meng Q, Recio L, Reilly AA, Wong BA, Bauer M, Walker VE. 1998b. Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats. Carcinogenesis 19:1019-1027.
23. Morley AA, Trainor KJ, Seshadri R, Ryall RG. 1983. Measurement of in vivo mutations in human lymphocytes. Nature 302:155-156.
24. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. 1995. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 92:4482-4486.
25. Qian F, Germino GG. 1997. "Mistakes happen": somatic mutation and disease. Am J Hum Genet 61:1000-1005.
26. Redhead NJ, Selfridge J, Wu CL, Melton DW. 1996. Mice with adenine phosphoribosyltransferase deficiency develop fatal 2,8-dihydroxyadenine lithiasis. Hum Gene Ther 7:1491-1502.
27. Shao C, Deng L, Henegariu O, Liang L, Raikwar N, Sahota A, Stambrook PJ, Tischfield JA. 1999. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice. Proc Natl Acad Sci USA 96:9230-9235.
28. Smith LE, Parks KK, Hasegawa LS, Eastmond DA, Grosovsky AJ. 1998. Targeted breakage of paracentromeric heterochromatin induces chromosomal instability. Mutagenesis 13:435-443.
29. Stambrook PJ, Shao C, Stockelman M, Boivin G, Engle SJ, Tischfield JA. 1996. APRT: a versatile in vivo resident reporter of local mutation and loss of heterozygosity. Environ Mol Mutagen 28:471-482.
30. Steglich C, DeMars R. 1982. Mutations causing deficiency of APRT in fibroblasts cultured from humans heterozygous for mutant APRT alleles. Somat Cell Mol Genet 8:115-141.
31. Stockelman MG, Lorenz JN, Smith FN, Bovine GP, Sahota A, Tischfield JA, Stambrook PJ. 1998. Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am J Physiol 275:F154-F163.
32. Tischfield JA. 1997. Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination. Am J Hum Genet 61: 995-999.
33. Tischfield JA, Ruddle FH. 1974. Assignment of the gene for adenine phosphoribosyltransferase to human chromosome 16 by mouse-human somatic cell hybridization. Proc Natl Acad Sci USA 71:45-49.
34. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S. 1992. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52:3099-3102.
35. Van Sloun PPH, Wijnhoven SWP, Kool JM, Weeda G, Slater R, Lohman PHM, van Zeeland AA, Vrieling H. 1998. Determination of spontaneous loss of heterozygosity mutation in Aprt heterozygous mice. Nucleic Acids Res 26:4888-4894.